<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-molecules-25-02529">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Huang</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Moschetti</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Lang</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Halabi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Petersen-Sylla</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Yong</surname>
    <given-names>C.-L.</given-names>
   </name>
   <name>
    <surname>Elgadi</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Pharmacokinetics, Safety, and Tolerability of Faldaprevir in Patients with Renal Impairment</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2014</year>
  <volume>59</volume>
  <fpage>251</fpage>
  <lpage>257</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.03359-14</pub-id>
  <pub-id pub-id-type="pmid">25348520</pub-id>
 </element-citation>
</ref>
